Re: sidual dysplasia

From: art fougner, md (evsono@pipeline.com)
Sat Jan 3 13:04:57 2004


the phen-fen combo was NOT an FDA approved use - the classic off-label disaster. OTH the classic ON - Label disaster was the Bendectin fiasco.

art

At Sat, 3 Jan 2004, Charlie Chambers wrote: >
>Art
>
>As long as some evidence supports the off label use, then it's a
>reasonable prescribing practice. We have so many medicines that do not
>have a "label" indication that are used every day but we are mostly
>unaware of the practice. For example, in preterm labor, ritodrine is
>the only tocolytic with FDA labeling for use. Yet, I can't remember the
>last time, I was aware of anyone using it. Further, the majority of
>medications used in the pediatric population do not have an FDA
>labeling use. Lastly, the FDA labeling doesn't protect you from any
>adverse or untoward events, e.g. Baychol, Phen-Fen, breast implants,
>and probably Prempro.
>
>On Jan 3, 2004, at 8:46 AM, art fougner, md wrote:
>
>> I don't believe MgSO4 was approved for eclampsia. and ASA antedates
>> the
>> FDA. OTH off label indications put the onus totally on the
>> practitioner
>> so ...
>>
>> art
>>
>> At Fri, 2 Jan 2004, RModugno@aol.com wrote:
>>>
>>> Content-Type: multipart/alternative;
>>> boundary="-----------------------------1073081945"
>>>
>>> boundary="-----------------------------1073081945"
>>> -------------------------------1073081945
>>> boundary="-----------------------------1073081945"
>>> Content-Type: text/plain; charset="US-ASCII"
>>> -------------------------------1073081945
>>> Content-Transfer-Encoding: 7bit
>>> -------------------------------1073081945
>>> In a message dated 1/2/2004 1:58:24 PM Eastern Standard Time,
>>> -------------------------------1073081945
>>> cchamber@gorge.net writes:
>>> I was then chastised
>>>> by a physician because I was using this off label
>>>> and was very liable for lawsuit. I discussed it
>>>> with the Aldara rep who, of course, could not
>>>> recommend that usage.
>>>
>>> Once a drug is apporved by the FDA - you can use it for "off-label"
>>> uses
>>> provided there is medical literature to back up this use.
>>> e.g.terbutaline is not approved for the treatment of premature labor.
>>>
>>> Robert Modugno MD MBA FACOG
>>> Marietta, GA
>>> http://www.novaobgyn.yourmd.com
>>>
>>> -------------------------------1073081945
>>> Content-Type: text/html; charset="US-ASCII"
>>> -------------------------------1073081945
>>> Content-Transfer-Encoding: quoted-printable
>>>
>>> In a message dated 1/2/2004 1:58:24 PM Eastern Standard Time,
>>> cchamber gorge.net writes:
>>> I was then chastised> by a physician b cause I was using this off
>>> label> and was very liable for lawsuit. I discussed it> with the
>>> Aldara rep who, of course, could not> ecommend that usage.
>>> Once a drug is apporved by the FDA - you can use it for "off-label"
>>> us s provided there is medical literature to back up this use.
>>> e.g.terbutaline is not approved for the treatment of premature labor.
>>>  
>>> Robert Modugno MD MBA FACOG
>>> Marietta, GA
>>> http://www.novaobgyn.yourmd.com
>>>
>>> -------------------------------1073081945--
>>>
>>> -------------------------------1073081945--
>>
>> --
>> art fougner, md
>> ich bin ein New Yorker
>>

--
art fougner, md
ich bin ein New Yorker




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:36:34 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.